Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v3-EN
Language French English
Date Updated 2019-07-16 2019-03-26
Drug Identification Number 02302187 02302187
Brand name SANDOZ CEFPROZIL SANDOZ CEFPROZIL
Common or Proper name CEFPROZIL CEFPROZIL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-04-30 2019-04-30
Actual start date 2019-03-18 2019-03-18
Estimated end date Unknown 2019-12-23
Actual end date 2019-07-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments